|
|  |
Gene Therapy Advisory Committee (GTAC) The
Gene Therapy Advisory Committee (GTAC) has UK-wide responsibility for the ethical
oversight of proposals to conduct clinical trials involving gene or stem cell
therapies. The Committee also advises Ministers on the development and use of
gene and stem cell therapies and works with other Government agencies with an
interest in this area, such as the Medicines and Healthcare products Regulatory
Agency (MHRA), the Health and Safety Executive (HSE) and the Human Tissue Authority
(HTA).
|
Whats New?
12 March 2009
The first version of an 'Interim UK Regulatory Route Map for Stem
Cell Research & Manufacture' has been released jointly by UK
regulators as a reference tool for those who wish to develop a programme
of stem cell research and manufacture, ultimately leading to clinical
application. The map has been developed by the Department of Health
with the support of the Gene Therapy Advisory Committee, Health
& Safety Executive, Home Office, Human Fertilisation & Embryology
Authority, Human Tissue Authority, Medicines & Healthcare products
Regulatory Agency, Medical Research Council, NHS Blood & Transplant
Authority, Scottish National Blood Transfusion Service, Advisory
Committee on the Safety of Blood, Tissues & Organs, & the
UK Stem Cell Bank.
Feedback on this map can be sent to: gtac@dh.gsi.gov.uk.
A more detailed, user-friendly, web-based version is currently being
developed and will be available by the end of 2009.
Interim UK Regulatory Route
Map for Stem Cell Research and Manufacture 
| |  |
Public
Health and Clinical Quality Genetics Human
Genetics Commission  
Download
Adobe Acrobat reader for PDF files Help
with Portable Document Format (PDF) |  |